On 16 October 2017, orphan designation (EU/3/17/1929) was granted by the European Commission to Envestia Limited, United Kingdom, for recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8 (also known as AK002) for the treatment of mastocytosis.
The sponsorship was transferred to Turnkey Pharmaconsulting Ireland Limited, Ireland, in October 2019.
Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8
|Disease / condition||
Treatment of mastocytosis
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.